Breast Cancer News

CancerConnect breast cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of breast cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of breast cancer treatment and survivorship.


Recent Breast Cancer News

Now Available: Hereditary Breast and Ovarian Cancer: What you need to know about risk and prevention (September 2, 2015)

Ask the Experts Series: A Family Affair: When Cancer Runs in the Family In this informative web chat, Megan Myers, M.S. discusses hereditary breast and ovarian cancer (HBOC) syndrome risk, genetic testing,... Continue Reading

Women with Early Breast Cancer Have Fewer Side Effects with Shorter Courses of Radiation (September 1, 2015)

Women with early breast cancer have fewer side effects when they’re treated with shorter courses of radiation at higher doses than with conventional radiation to the whole breast. These findings were... Continue Reading

Role of Tumor Size and Estrogen-Receptor Status in Decline in Breast Cancer Deaths (August 4, 2015)

In light of a general decline in breast cancer death since the late 1980s, research has now turned to how type and stage of disease affect survival among different women. These findings, which considered... Continue Reading

Breast cancer treatment with fewer potential side effects has equally good patient outcomes, UCLA study shows (July 2, 2015)

A new study by UCLA scientists has found that women diagnosed with breast cancer and treated with a one-week regimen of partial breast radiation after the surgical removal of the tumor, or lumpectomy,... Continue Reading

Arimidex® More Effective than Tamoxifen in Prevention of Recurrence in Early Breast Cancer (June 9, 2015)

For patients with a common type of breast cancer known as ductal carcinoma in situ (DCIS), the drug Arimidex® (anastrozole) may provide better protection against recurrence than tamoxifen. These findings... Continue Reading

Combination of Ibrance® plus Faslodex® Promising in Advanced Hormone-Positive Breast Cancer (June 3, 2015)

The combination of Ibrance® (palbociclib) and Faslodex® (fulvestrant) appears to extend progression-free survival in women with estrogen receptor (ER)-positive, human epidermal growth factor receptor... Continue Reading

Combination of Iniparib, Gemzar®, and Carboplatin Active in Initial Treatment of Early-Stage Triple-Negative Breast Cancer (June 2, 2015)

The combination of iniparib, Gemzar® (gemcitabine), and carboplatin appears promising in the initial treatment of patients with early-stage triple-negative breast cancer with a BRCA1/2 mutation. In addition,... Continue Reading

Platinum-Based Chemotherapy Active in Metastatic Triple-Negative Breast Cancer (May 26, 2015)

Platinum-based chemotherapy appears active in the treatment of metastatic triple-negative breast cancers, particularly among patients with a BRCA1/2 mutation. These findings were reported in the Journal... Continue Reading

Dose-Dense Chemotherapy with Ellence®, Cytoxan®, and Taxol® May Improve Survival in Node-Positive Breast Cancer (April 30, 2015)

Patients with early-stage node-positive breast cancer who receive dose-dense adjuvant chemotherapy with Ellence® (epirubicin), Cytoxan® (cyclophosphamide), and Taxol® (paclitaxel) may have improved... Continue Reading

The Importance of Awareness of Breast Density and Its Impact on Cancer Screening and Risk (April 23, 2015)

Women in the United States may not be adequately aware of breast density and its complications. Legislation that requires providers to discuss a woman’s breast density is likely to help build awareness.... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS